ALEC (STOCKS)
Alector, Inc. Common Stock
$1.570000
+0.040000 (+2.61%)
Prev close: $1.530000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Arnon Rosenthal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $174.31M
- Employees
- 163
- P/E (TTM)
- -1.29
- P/B (TTM)
- 16.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
4
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.21 | $-0.35 | +0.1397 | +39.95% |
|
Dec 2025 (Q4)
|
$-0.34 | $-0.39 | +0.0514 | +13.13% |
|
Sep 2025 (Q3)
|
$-0.34 | $-0.42 | +0.0757 | +18.21% |
|
Jun 2025 (Q2)
|
$-0.30 | $-0.47 | +0.1692 | +36.06% |
Financial Statements
| Revenues | $18.42M |
| Benefits Costs and Expenses | $143.64M |
| Costs And Expenses | $143.64M |
| Operating Expenses | $154.65M |
| Depreciation and Amortization | $5.82M |
| Research and Development | $107.28M |
| Other Operating Expenses | $45.12M |
| Operating Income/Loss | -$136.23M |
| Income/Loss From Continuing Operations After Tax | -$125.39M |
| Income/Loss From Continuing Operations Before Tax | -$125.22M |
| Income Tax Expense/Benefit | $168.00K |
| Net Income/Loss | -$125.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$125.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$125.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.19 |
| Diluted Earnings Per Share | -$1.19 |
| Basic Average Shares | 315,757,362 |
| Diluted Average Shares | 315,757,362 |
| Assets | $239.92M |
| Current Assets | $215.08M |
| Noncurrent Assets | $24.83M |
| Fixed Assets | $9.93M |
| Other Non-current Assets | $14.90M |
| Liabilities | $229.53M |
| Current Liabilities | $40.97M |
| Accounts Payable | $1.42M |
| Other Current Liabilities | $39.54M |
| Noncurrent Liabilities | $188.57M |
| Equity | $10.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.38M |
| Liabilities And Equity | $239.92M |
| Net Cash Flow From Operating Activities | -$173.06M |
| Net Cash Flow From Operating Activities, Continuing | -$173.06M |
| Net Cash Flow From Investing Activities | $191.81M |
| Net Cash Flow From Investing Activities, Continuing | $191.81M |
| Net Cash Flow From Financing Activities | $25.19M |
| Net Cash Flow From Financing Activities, Continuing | $25.19M |
| Net Cash Flow | $43.94M |
| Net Cash Flow, Continuing | $43.94M |
| Comprehensive Income/Loss | -$125.59M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$125.68M |
| Other Comprehensive Income/Loss | -$34.87M |
| Other Comprehensive Income/Loss Attributable To Parent | -$295.00K |